Zobrazeno 1 - 10
of 22
pro vyhledávání: '"S R, George"'
Publikováno v:
Cerebral Cortex. 19:153-164
The 22q11.2 deletion syndrome (22qDS) is the most common microdeletion syndrome in humans. Its multisystem manifestations include congenital anomalies and neuropsychiatric disorders such as schizophrenia. Structural neuroimaging shows various abnorma
Publikováno v:
British journal of pharmacology. 161(5)
µ- and δ-opioid receptors form heteromeric complexes with unique ligand binding and G protein-coupling profiles linked to G protein α z-subunit (Gα(z) ) activation. However, the mechanism of action of agonists and their regulation of the µ-δ re
Autor:
Rachel F. Tyndale, E H Cook, T Nguyen, Edward M. Sellers, M D Thompson, Brian F. O'Dowd, D Zarrabian, George R. Uhl, D E Comings, S R George, David J. Vandenbergh, Matthew D. Krasowski, E Bendahhou
Publikováno v:
Molecular psychiatry. 5(3)
The dopamine transporter (DAT) provides major regulation of the synaptic levels of dopamine and is a principal target of psychostimulant drugs. Associations between DAT gene polymorphisms and human disorders with possible links to dopaminergic neurot
Publikováno v:
The Journal of biological chemistry. 275(34)
The existence of dimers and oligomers for many G protein-coupled receptors has been described by us and others. Since many G protein-coupled receptor subtypes are highly homologous to each other, we examined whether closely related receptors may inte
Publikováno v:
Molecular pharmacology. 57(4)
Two G protein-coupled receptors (Edg-2) and (Edg-4) for the lysolipid phosphoric acid mediator lysophosphatidic acid have been described by molecular cloning. However, the calcium-mobilizing receptor Edg-4 is not expressed in some cell lines that exh
Publikováno v:
The Journal of biological chemistry. 274(39)
The mu opioid receptor (MOR) has been shown to desensitize after 1 h of exposure to the opioid peptide, [D-Ala(2), N-MePhe(4), Gly-ol(5)]enkephalin (DAMGO), largely by the loss of receptors from the cell surface and receptor down-regulation. We have
Publikováno v:
American journal of medical genetics. 81(3)
We report a single stranded conformational polymorphism (SSCP) analysis of the coding region of the dopamine D1 receptor (DRD1) in Tourette's syndrome (n = 50) and control (n = 50) subjects. Tourette's syndrome populations with comorbidity for attent
Publikováno v:
Endocrinology. 138(10)
Dopamine D2 receptor agonists are commonly used in the control of PRL-secreting adenomas, and the sensitivity of dopamine agonists during long term therapy is exquisite. However, the molecular mechanisms responsible for the maintenance of this cellul
Publikováno v:
Molecular pharmacology. 50(5)
The effects of acute exposure of the opioid peptide [D-Ala2,N-MePhe4, Gly-ol5]enkephalin (DAMGO) on the mu-opioid receptor were examined in Chinese hamster ovary (CHO) K-1 and baby hamster kidney stable transfectants. In the CHO cell line, acute 1-hr
Publikováno v:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 43(5)
A c-myc epitope-tagged human dopamine D1 receptor (c-myc D1 receptor) was expressed in Sf9 cells and its cellular distribution under basal conditions and after exposure to the agonist dopamine was examined. In the basal state, immunofluorescently lab